Charles Riv­er Lab­o­ra­to­ries to start cell and gene ther­a­py man­u­fac­tur­ing at UK site in Sep­tem­ber

While Mass­a­chu­setts-based Charles Riv­er Lab­o­ra­to­ries has been on an ac­qui­si­tion spree, they are not against plant­i­ng their flag. The lat­est move by the com­pa­ny sees them cross­ing the pond to es­tab­lish a man­u­fac­tur­ing site in the UK.

The com­pa­ny on Tues­day opened its cell and gene ther­a­py man­u­fac­tur­ing cen­ter at Brunt­wood SciTech’s Alder­ley Park in Cheshire, Unit­ed King­dom. The ex­pan­sion fol­lows Charles Riv­er’s ac­qui­si­tion of Cog­nate BioSer­vices and Co­bra Bi­o­log­ics in 2021 for $875 mil­lion. Cog­nate is a plas­mid DNA, vi­ral vec­tor and cell ther­a­py CD­MO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER